Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

AbbVie : to Host Third-Quarter 2020 Earnings Conference Call

10/07/2020 | 11:23am EST

NORTH CHICAGO, Ill. - AbbVie (NYSE: ABBV) will announce its third-quarter 2020 financial results on Friday, October 30, 2020, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Contact:

Media

Adelle Infante

(847) 938-8745

Adelle.Infante@abbvie.com

Investors

Liz Shea

(847) 935-2211

Liz.Shea@abbvie.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about ABBVIE INC.
11/25ABBVIE : to Present at the Evercore ISI Conference and Piper Sandler Healthcare ..
AQ
11/24ABBVIE : to Present at the Evercore ISI Conference and Piper Sandler Healthcare ..
PR
11/19ABBVIE : Announces Expiration and Final Results of Registered Exchange Offers
AQ
11/18ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/18ABBVIE : Announces Expiration and Final Results of Registered Exchange Offers
PR
11/18Berkshire's bet a bright spot in gloomy year for Big Pharma stocks
RE
11/17S&P, Dow futures retreat as coronavirus cases spike
RE
11/17ABBVIE : Allergan Aesthetics Celebrates Second Annual BOTOX Cosmetic Day
AQ
11/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/17NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
Financials (USD)
Sales 2020 45 625 M - -
Net income 2020 12 365 M - -
Net Debt 2020 74 478 M - -
P/E ratio 2020 25,6x
Yield 2020 4,51%
Capitalization 185 B 185 B -
EV / Sales 2020 5,68x
EV / Sales 2021 4,62x
Nbr of Employees 47 000
Free-Float 98,5%
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 112,00 $
Last Close Price 104,58 $
Spread / Highest target 21,4%
Spread / Average Target 7,10%
Spread / Lowest Target -7,25%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.18.47%185 181
JOHNSON & JOHNSON-1.28%379 086
ROCHE HOLDING AG-3.66%285 972
PFIZER INC.0.30%206 939
NOVARTIS AG-11.80%203 829
MERCK & CO., INC.-12.19%202 049